|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Lipid Sciences, Inc. (LIPD)' Atherosclerosis Regression Data Presented at EuroPCR 2008 Congress
5/14/2008 11:03:51 AM
PLEASANTON, CA--(Marketwire - May 14, 2008) - Lipid Sciences, Inc. (NASDAQ: LIPD) -- Dr. Ron Waksman, Associate Director, Division of Cardiology, Washington Hospital Center, Washington, D.C., presented preliminary results and new clinical safety data supporting Lipid Sciences' HDL Selective Delipidation technology during a Late-Breaking Trials session at the EuroPCR 2008 Congress in Barcelona, Spain, yesterday. Dr. Waksman, an internationally-recognized interventional cardiologist, was the principal investigator for the Company's clinical trial, "A Randomized Single-Blind Placebo-Controlled Study to Evaluate the Safety of Lipid Sciences' PDS-2 in Subjects with Acute Coronary Syndrome (ACS)."
|
|
|
|
|
|
|
|
|
|
|